← Back to guidelines
Neurology4 papers

Combined focal and generalized epilepsy

Last edited: 4/10/2026

Overview

Depressive disorders are a common psychiatric comorbidity in individuals with epilepsy, affecting approximately one-third of this population and significantly impacting quality of life 2. There is uncertainty regarding optimal antidepressant selection and the potential risk of seizure exacerbation 2.

Diagnosis

Management

  • Antidepressants are used to treat depressive symptoms in people with epilepsy 2.
  • The efficacy and safety of various antidepressants and their effect on seizure recurrence are evaluated 2.
  • Special Populations

    Key Recommendations

  • Antidepressants are evaluated for their efficacy and safety in treating depressive symptoms and their effect on seizure recurrence in people with epilepsy and depression 2.
  • Research aims to inform clinical practice and future research regarding the best antidepressant choices for individuals with epilepsy and depression 2.
  • Potential pleiotropic genes and shared biological pathways between epilepsy and depression are being investigated, suggesting a possible overlapping genetic foundation 1.
  • References

    1 Lin H, Lin WH, Lin F, Liu CY, Che CH, Huang HP. Potential Pleiotropic Genes and Shared Biological Pathways in Epilepsy and Depression Based on GWAS Summary Statistics. Computational intelligence and neuroscience 2022. link 2 Maguire MJ, Marson AG, Nevitt SJ. Antidepressants for people with epilepsy and depression. The Cochrane database of systematic reviews 2021. link

    Original source

    1. [1]
      Potential Pleiotropic Genes and Shared Biological Pathways in Epilepsy and Depression Based on GWAS Summary Statistics.Lin H, Lin WH, Lin F, Liu CY, Che CH, Huang HP Computational intelligence and neuroscience (2022)
    2. [2]
      Antidepressants for people with epilepsy and depression.Maguire MJ, Marson AG, Nevitt SJ The Cochrane database of systematic reviews (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG